Remarkably, KIT is often overexpressed in CBF leukemia concomitantly with miR-222-221 downregulation [133], suggesting that miR-222-221 may be under the transcriptional control of CBF (i.e., RUNX1 and CBFB). This evidence concerns the gene KIT and leukemia.